BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 947523)

  • 1. Survival and complications of radiotherapy following involved and extended field therapy of Hodgkin's disease, stages I and II. A collaborative study.
    Nickson JJ; Fuller LM; Hutchison GB; Kaplan HS; Karnofsky D; Lee BJ; Peters MV
    Cancer; 1976 Jul; 38(1):288-305. PubMed ID: 947523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of involved field and extended field radiotherapy in patients with pathologic state I and II Hodgkin's disease.
    Miller JB; Moran EM; Desser RK; Griem ML; Ultmann JE
    AJR Am J Roentgenol; 1976 Nov; 127(5):833-9. PubMed ID: 973673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy of stage I and II Hodgkin's disease. A collaborative study.
    Cancer; 1984 Nov; 54(9):1928-42. PubMed ID: 6478427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease in children.
    Smith IE; Peckham MJ; McElwain TJ; Gazet JC; Austin DE
    Br J Cancer; 1977 Jul; 36(1):120-9. PubMed ID: 889679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative clinical trial for stage I and II Hodgkin's disease: significance of mediastinal and nonmediastinal disease in laparotomy- and non-laparotomy-staged patients.
    Fuller LM; Hutchison GB
    Cancer Treat Rep; 1982 Apr; 66(4):775-87. PubMed ID: 7074648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B; Brady LW
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980).
    Cornbleet MA; Vitolo U; Ultmann JE; Golomb HM; Oleske D; Griem ML; Ferguson DJ; Miller JB
    J Clin Oncol; 1985 Jun; 3(6):758-68. PubMed ID: 4009215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
    Dühmke E; Franklin J; Pfreundschuh M; Sehlen S; Willich N; Rühl U; Müller RP; Lukas P; Atzinger A; Paulus U; Lathan B; Rüffer U; Sieber M; Wolf J; Engert A; Georgii A; Staar S; Herrmann R; Beykirch M; Kirchner H; Emminger A; Greil R; Fritsch E; Koch P; Drochtert A; Brosteanu O; Hasenclever D; Loeffler M; Diehl V
    J Clin Oncol; 2001 Jun; 19(11):2905-14. PubMed ID: 11387364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease treated with radiation therapy: follow-up data and the value of laparotomy.
    Prosnitz LR; Fischer JJ; Vera R; Kligerman MM
    Am J Roentgenol Radium Ther Nucl Med; 1972 Mar; 114(3):583-90. PubMed ID: 4622154
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effects.
    Cutuli B; Petit T; Hoffstetter S; Velten M; Dufour P; Giron C; Lederlin P; Jung GM; Bergerat JP; Maloisel F; Bey P; Oberling F
    Oncol Rep; 1998; 5(6):1513-8. PubMed ID: 9769397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involved field radiation therapy for early stage Hodgkin's disease in children: preliminary results.
    Cham WC; Tan CT; Martinez A; Exelby PR; Tefft M; Middleman P; D'Angio GJ
    Cancer; 1976 Apr; 37(4):1625-32. PubMed ID: 1260679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term (15 years) results of extended field radiotherapy in Hodgkin's disease.
    Sevcíková EL; Boljesíková E; Chorváth M; Kovacicová G
    Neoplasma; 2000; 47(4):253-6. PubMed ID: 11043832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease stage I and II. A comparison between two different treatment policies.
    Stoffel TJ; Cox JD
    Cancer; 1977 Jul; 40(1):90-7. PubMed ID: 406982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tirelli U; Bortolus R; van 't Veer MB; Lybeert ML; Keuning JJ; Carde P; Girinsky T; van der Maazen RW; Tomsic R; Vovk M; van Hoof A; Demeestere G; Lugtenburg PJ; Thomas J; Schroyens W; De Boeck K; Baars JW; Kluin-Nelemans JC; Carrie C; Aoudjhane M; Bron D; Eghbali H; Smit WG; Meerwaldt JH; Hagenbeek A; Pinna A; Henry-Amar M;
    N Engl J Med; 2003 Jun; 348(24):2396-406. PubMed ID: 12802025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.